Renal Diseases Market Reports Empesis on Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease

The Frontier Pharma: Renal Diseases High Degree of Innovation and Diversity with Products Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease assesses first-in-class innovation in the renal diseases pipeline, highlighting key trends and emerging treatment classes.

Pune, India - March 14, 2018 /MarketersMedia/ —

The renal diseases therapy area encompasses a range of diseases of the kidney, such as chronic kidney disease (CKD), acute kidney injury, diabetic nephropathy and focal segmental glomerulosclerosis. Renal diseases are becoming increasingly common due to the increased prevalence of hypertension and diabetes, two major causes of CKD. For most forms of renal diseases, early detection and management may slow down or prevent progression to renal failure and associated complications. However, many renal diseases are typically asymptomatic until they have progressed to end-stage renal disease (ESRD), which requires renal replacement therapies such as hemodialysis and renal transplantation, and is associated with substantial morbidity and mortality.

Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-renal-diseases-high-degree-of-innovation-and-diversity-with-products-targeting-immune-and-hormone-signaling-dominating-the-pipeline-for-chronic-kidney-disease

The first-in-class programs identified show considerable diversity, and the relatively high degree of innovation in the renal diseases therapy area makes for a promising development pipeline. It is clear that recent activity in this area has increased, partly owing to the growing recognition of the unmet medical need. Further investment in innovation would benefit the therapy area greatly, and likely prove a worthwhile investment, particularly for highly prevalent diseases such as CKD and diabetic nephropathy, for which there are a lack of effective pharmacotherapeutic options.

Get this report at: https://www.themarketreports.com/report/buy-now/935551

Scope
• With 365 products in active development, the pipeline is modestly sized. Does current pipeline innovation hold the potential to affect the future renal diseases market?
• There are 100 first-in-class products in the renal diseases pipeline. Which of these hold the greatest potential to improve future disease treatment with regard to their molecular target?
• The majority of first-in-class products were in development for indications involving inflammation. Which first-in-class targets are most promising, and how does the ratio of first-in-class targets to first-in-class products differ by stage of development and molecular target class?
• A significant number of first-in-class products have been identified with no prior involvement in deals. How do deal frequency and value compare between target families and molecule types, and which first-in-class programs have not yet been involved in a licensing or co-development deal?

Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935551

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/renal-diseases-market-reports-empesis-on-targeting-immune-and-hormone-signaling-dominating-the-pipeline-for-chronic-kidney-disease/314328

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-renal-diseases-high-degree-of-innovation-and-diversity-with-products-targeting-immune-and-hormone-signaling-dominating-the-pipeline-for-chronic-kidney-disease%20%20

Source: MarketersMedia

Release ID: 314328

Latest News

Global shares edge up, China pulls Asia down, oil subdued pre: OPEC

Jun 21, 2018

By Wayne ColeSYDNEY (Reuters) - Shares crept higher in most major markets on Thursday as a lull in the Sino-U.S. trade tussle and talk of more stimulus in China helped calm nerves, though the nagging trade tensions caused Chinese shares to slip, dragging other Asian markets lower.Oil prices eased a touch as nerves grew ahead of Friday's meeting between OPEC and other big producers, including Russia, with growing expectations that the Vienna talks could result in an agreement to increase crude supplies. [O/R]European shares are expected to rise, with spread-betters calling a higher opening of 0.4 percent in Britain's FTSE...

European autos sink on Daimler tariff hit while markets wilt

Jun 21, 2018

By Helen ReidLONDON (Reuters) - Autos stocks slammed the brakes on a relief bounce in European shares on Thursday, sinking after German carmaker Daimler warned profit would be hit by higher tariffs.The autos sector fell 2.3 percent to a nine-month low while the pan-European STOXX 600 eased down 0.2 percent as no new salvos were exchanged in an ongoing U.S.-China trade spat.Equity markets have been relatively resilient in the face of mounting trade concerns but fell broadly this week as U.S. President Donald Trump threatened additional tariffs on $200 billion worth of Chinese goods.Daimler became one of the biggest global...

May faces down pro-EU rebel lawmakers to win Brexit vote

Jun 21, 2018

By Elizabeth Piper and William JamesLONDON (Reuters) - Prime Minister Theresa May won a crucial Brexit vote in parliament on Wednesday, keeping her divided government's plans to end more than 40 years of British partnership with the European Union on track.After pro-EU Conservative lawmaker Dominic Grieve said he would support the government's proposal for a "meaningful vote" in parliament on Britain's exit, a potential rebellion that could have undermined May's authority was averted.May adopted a high-risk strategy by facing off with rebels in her Conservative Party, and it paid off. The upper house of parliament later approved the bill, paving...

Exclusive: Pope criticizes Trump administration policy on migrant family separation

Jun 21, 2018

By Philip PullellaVATICAN CITY (Reuters) - Pope Francis has criticized the Trump administration's policy of separating migrant families at the Mexican border, saying populism is not the answer to the world's immigration problems.Speaking to Reuters, the Pope said he supported recent statements by U.S. Catholic bishops who called the separation of children from their parents "contrary to our Catholic values" and "immoral"."It's not easy, but populism is not the solution," Francis said on Sunday night.In a rare, wide-ranging interview, the pope said he was optimistic about talks that may lead to a historic agreement over the appointment of bishops in...

Exclusive: Pope says China talks going well, dialogue worth the risk

Jun 21, 2018

By Philip PullellaVATICAN CITY (Reuters) - Pope Francis has voiced optimism for improved ties between the Vatican and China, rejecting criticism that the Holy See may be selling out Catholics to Beijing's communist government.The Vatican and China are in advanced talks to resolve a dispute over the appointment of bishops in China, one of the biggest obstacles to resuming diplomatic ties that were cut almost 70 years ago."We are at a good point," the pope told Reuters in an interview at his Vatican residence.China's estimated 12 million Catholics are split between an underground Church that swears loyalty to the Vatican...

Search

Obserworld delivers the most accurate and up-to-date world news for the global audience with a thorough research and in-depth interviews. Discover the world through Obserworld.

Contact us: sales[at]obserworld.com